Genetic mutations have been identified as the cause of inherited cancer risk in some colon cancer; these mutations are estimated to account for only 5–6 % of colorectal cancer (CRC) cases overall. Up to 25–30 % of patients have a family history of CRC that suggests a hereditary component, common exposures among family members, or a combination of both. Cancers in people with a hereditary predisposition typically occur at an earlier age than in sporadic cases. A predisposition to CRC may include a predisposition to other cancers, such as endometrial cancer. We describe genetics, current diagnosis and management of CRC hereditary syndromes pointing to a multidisciplinary approach to achieve the best results in patients and family outcomes.
CITATION STYLE
Guillén-Ponce, C., Serrano, R., Sánchez-Heras, A. B., Teulé, A., Chirivella, I., Martín, T., … Robles, L. (2015). Clinical guideline seom: hereditary colorectal cancer. Clinical and Translational Oncology, 17(12), 962–971. https://doi.org/10.1007/s12094-015-1439-z
Mendeley helps you to discover research relevant for your work.